白细胞介素12在结核性胸膜炎诊断中的应用价值(2)
 |
| 第1页 |
参见附件(1474KB，2页)。
参 考 文 献
[1] Trajman A, Pai M, Dheda K, et al. Novel tests for diagnosing tuberculous pleural effusion: what works and what does not.Eur Respir J, 2008,31(5):10981106.
[2] Gopi A, Madhavan SM, Sharma SK, et al. Diagnosis and treatment of tuberculous pleural effusion in,2006.Chest,2007,131(3):880889.
[3] Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician, 2006,73(7):12111220.
[4] Shirakabe A, Hata N, Yokoyama S, et al. Cytokine levels in pleural effusions of patients under intensive care. J Nippon Med Sch, 2008,75(5):262268.
[5] Heffner JE, Klein JS. Recent advances in the diagnosis and management of m alignant pleural effusions. Mayo Clin Proc, 2008,83(2):235250.
[6] Li D, Yu H, Xu TF, et al. Interleukin12 gene modification exerts antitumor effects on murine mammary sarcoma cell line in vivo. Cell Mol Immunol, 2008,5(3):225230.
[7] 宋鉴清,李 平,赵 敏IL6、IL10、IL12在胸腔积液鉴别诊断中的应用.中国医学检验杂志,2004,5(2):114115
[8] Kinjo Y, Kawakami K, Uezu K,et al.Contribution of IL18 to Th1 response and host defense against infection by Mycobacterium tuberculosis:a comparative study with IL12p40. J Immunol, 2002,169(1):323329.
[9] Chen H, Brahmer J. Management of m alignant pleural effusion. Curr Oncol Rep, 2008,10(4): 287293.
[10] Jurisic V, StojacicDjenic S, Colovic N, et al. The role of cytokine in regulation of the natural killer cell activity.Srp Arh Celok Lek, 2008,136(78):423429.
您现在查看是摘要介绍页，详见PDF附件(1474KB，2页)。